CALR and Alzheimer disease: Indeed, large studies have demonstrated that anti-Ro/SSA-antibodies can be also detected in a significant proportion of subjects of the general population (0.5-2.7%) (41–43), who are in most cases (60%) asymptomatic for AD (43), particularly when anti-Ro/SSA-52kD positivity occurs alone (44).